Non Cognitive Neuropsychiatric Impairments in Alzheimer’s Disease
نویسندگان
چکیده
Methods: 131 patients with AD (mild, moderate degree) were included in the investigation according to the diagnostic criteria of DSM IV and MKB 10. 45 AD patients were on galantamine, 43-memantin and 43-combined therapy. The control group includes 45 patients. In our investigation in the main group of AD patients the duration of the disease was from 6 months to 4.3 years, on average 3.3 years. Standard neuropsychological an investigation was performed in AD and control group which included the following testsMMSE: Mini Mental State Examination, FAB: Frontal Assessment Battery), clock drawing test, 12 world list immediate and delayed recall (subscore, total). Neuropsychiatric investigation includes neuropsychyatric inventory (NPI-Cummings).
منابع مشابه
Herbal help in Alzheimer’s type of cognitive disorders: A Comprehensive Review
Alzheimer’s disease is the most frequent type of life threatening dementia which is characterized by oxidative stress and inflammation induced neuronal loss, impaired energy metabolism, and cholinergic deficits leading to severe cognitive impairments and other abnormal neuropsychiatric changes. Cure of cognitive disorders such as amnesia, attention deficit and Alzheimer’s disease is still a nig...
متن کاملα7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer’s Disease
Accumulating evidence suggests that α7 nicotinic receptors (α7 nAChRs), a subtype of nAChRs, play a role in the pathophysiology of neuropsychiatric diseases, including schizophrenia and Alzheimer's disease (AD). A number of psychopharmacological and genetic studies shown that α7 nAChRs play an important role in the deficits of P50 auditory evoked potential in patients with schizophrenia, and th...
متن کاملCognitive dysfunctions in hepatitis C virus (HCV) infection. A mini review
Hepatitis C virus (HCV) infection is often associated with different neuropsychiatric disturbances including various cognitive symptoms. These impairments , which affect up to 50% of all subjects, are very often reported by the patients , but generally receive poor attention, and are very rarely investigated and measured with standardized tests. This review aims to describe these symptoms, the ...
متن کاملNew Insights into the Effect of Diabetes and Obesity in Alzheimer’s Disease
Abstract Alzheimer’s disease (AD) is the most common cause of dementia in elderly people. The prevalence of Alzheimer diseases is increasing in the world due to population aging. Metabolic disease such as diabetes and obesity play important role in Alzheimer disease. Hyperglycemia can play important role in brain damage. It causes cognitive impairments, functional and structural alterations in...
متن کاملAmelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease
BACKGROUND Patients suffering from Parkinson's disease (PD) display cognitive and neuropsychiatric dysfunctions, especially with disease progression. Although these impairments have been reported to impact more heavily upon a patient's quality of life than any motor dysfunctions, there are currently no interventions capable of adequately targeting these non-motor deficits. OBJECTIVES Utilizin...
متن کامل